2 completed, 1 active not recruiting, 1 terminated, 1 unknown. 6 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 2, Active not recruiting 1, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 3 | Terminated 1, Unknown 1, Withdrawn 1 |
Follow Azacitidine Injection: new trials by email Literature Review of Azacitidine Injection trials Research Report on Azacitidine Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX] NP137, Azacitidine Injection, Venetoclax - Acute Myeloid Leukemia Refractory | Phase 1 / Phase 2 | Terminated | Centre Leon Berard | 1 | 2024-09-11 | 2025-02-20 |
| Azacytidine During Anti-tuberculosis Therapy Azacitidine Injection - Tuberculosis, Pulmonary | Phase 1 / Phase 2 | Withdrawn | Andrew Dinardo | 2022-10-01 | 2023-02-08 | |
| A Umbrella Study in R/R PTCL Guided by Molecular Subtypes Azacitidine Injection, Dasatinib, Linperlisib - Peripheral T Cell Lymphoma | Phase 1 / Phase 2 | Unknown | Ruijin Hospital | 116 | 2022-09-30 | 2022-11-09 |
| Pharmacokinetics, Tolerability and Safety of NEX-18a NEX-18a injection, Azacitidine Injection - Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) | Phase 1 | Completed | Nanexa AB | 2 | 2021-04-27 | 2023-10-17 |
| Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation Vorinostat, Azacitidine Injection - Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | Active not recruiting | Johns Hopkins All Children's Hospital | 15 | 2019-05-01 | 2026-07-15 |
| Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment Azacitidine Injection, sodium phenylbutyrate - Lymphoma, Small Intestine Cancer | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 34 | 2000-03-01 | 2019-01-11 |
Leukemia, Myeloid, Acute (3) · Myelodysplastic Syndromes (2) · Burkitt Lymphoma (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Intraocular Lymphoma (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelomonocytic, Chronic (1) · Leukemia, Myelomonocytic, Juvenile (1) · Lymphoma (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Anaplastic (1)
Andrew Dinardo (1) · Centre Leon Berard (1) · Johns Hopkins All Children's Hospital (1) · Nanexa AB (1) · Ruijin Hospital (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
United States (3) · China (1) · France (1) · Sweden (1)
Andrew DiNardo (1) · Cassandra Josephson, MD (1) · Michael A. Carducci, MD (1) · Weili Zhao (1)
P30CA006973 (1), P50CA058236 (1), R01CA075525 (1), U01CA070095 (1)